79392046 - ACELLYTRON

Information

• Trademark
• 79392046

• Source

• Serial Number

  79392046

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 28, 2023
  11 months ago

• Transaction Date

  October 11, 2024
  a month ago

• Status Date

  October 10, 2024
  a month ago

• Location Date

  October 10, 2024
  a month ago

• Status Code

  661

• Current Location

  INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)

  Employee Name

  THOMAS, JULIE

• Attorney Docket Number

  0904-0253US1

  Attorney Name

  Michael T. Smith

  Law Office Assigned Location Code

  L70

• Owners

  • WuXi Biologics Co., Ltd.

Case File Statements

• GS0051: Chemical-pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; biochemical medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for medical purposes, namely medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely biologic preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; oncolytic viral therapies; medical cell inhibitor, namely protein, antibody and small molecule inhibitor; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely tumor suppressor; cells for use medical use; dietetic food and substances adopted for medical use; biological preparations for veterinary purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease
• GS0351: Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
• GS0441: Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance
• GS0421: Research and development of new products for others; technological research in the field of pharmaceutical studies, cell separation and cell culture; chemical analysis; biochemistry research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely conducting clinical trials for others; biological research; computer programming in the field of medical aspects

Case File Event Statements

• 3/27/2024 - 7 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/26/2024 - 4 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/26/2024 - 4 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/27/2024 - 4 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/21/2024 - 7 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 3/23/2024 - 7 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/11/2024 - 3 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 10/10/2024 - a month ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/10/2024 - a month ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/10/2024 - a month ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/18/2024 - 4 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 7/18/2024 - 4 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS